Mediolanum International Funds’s Bristol-Myers Squibb BMY Stock Holding History

Mediolanum International Funds’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32M	Sell	545,919 -841,219	-61%	-$48.3M	0.27%	82
2026 Q1	$82.9M	Buy	1,387,138 +145,209	+12%	+$8.46M	0.88%	16
2025 Q4	$67.3M	Buy	1,241,929 +732,938	+144%	+$35.3M	0.67%	24
2025 Q3	$22.5M	Buy	508,991 +197,940	+64%	+$9.24M	0.24%	99
2025 Q2	$14.4M	Buy	311,051 +113,585	+58%	+$5.58M	0.17%	149
2025 Q1	$11.9M	Buy	197,466 +104,854	+113%	+$6.11M	0.16%	139
2024 Q4	$5.18M	Buy	92,612 +4,085	+5%	+$228K	0.07%	234
2024 Q3	$4.5M	Buy	88,527 +484	+0.5%	+$22.7K	0.06%	259
2024 Q2	$3.41M	Sell	88,043 -145,993	-62%	-$6.53M	0.06%	258
2024 Q1	$12.5M	Buy	+234,036	New	+$11.9M	0.2%	111

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mediolanum International Funds's BMY Position: Q2 2026 in Review

Mediolanum International Funds reduced its Bristol-Myers Squibb (BMY) stake by 61% in Q2 2026, selling an estimated $48.3M and leaving 545,919 shares worth $32M. The position accounts for 0.27% of the portfolio, ranked #82.

Mediolanum International Funds first reported a position in BMY in Q1 2024 and has held it in 10 quarters since. The position peaked at $82.9M in Q1 2026. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Mediolanum International Funds held 545,919 shares of Bristol-Myers Squibb worth $32M as of Q2 2026.
Mediolanum International Funds sold 841,219 Bristol-Myers Squibb shares in Q2 2026, an estimated $48.3M.
Bristol-Myers Squibb made up 0.27% of Mediolanum International Funds's portfolio in Q2 2026, its #82 holding.
Mediolanum International Funds first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 10 quarters since.
Mediolanum International Funds's Bristol-Myers Squibb position peaked at $82.9M in Q1 2026.
2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.